Howard JF Jr, Sacca F, Hoffmann S, Attarian S, et al. Clinical effectiveness of efgartigimod in a broad population of patients with generalized myasthenia gravis: subgroup analyses from a randomized, double?blind, placebo?controlled, phase 3 trial (ADAPT). J Neurol 2026;273:363.
PMID: 42234197